Lately, EZH2 independent effects of SAM-competitive EZH2 inhibitors have been shown in hepatocellular carcinoma cell lines and correlated with an induction of expression of the transcription factor SRE binding protein [39]. Here, EZH2 is linked to hepatocellular carcinoma.